The ZEB2‐dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer-Reference-Cited by-同舟云学术

The ZEB2‐dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer

Published:2021-05 Issue:8 Volume:15 Page:2065-2083
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Sreekumar Rahul¹,Al‐Saihati Hajir¹²,Emaduddin Muhammad¹,Moutasim Karwan¹,Mellone Massimiliano¹,Patel Ashish¹,Kilic Seval¹,Cetin Metin³,Erdemir Sule³,Navio Marta Salgado¹,Lopez Maria Antonette¹,Curtis Nathan⁴,Yagci Tamer³,Primrose John N.¹⁴,Price Brendan D.⁵,Berx Geert⁶⁷,Thomas Gareth J.¹,Tulchinsky Eugene⁸,Mirnezami Alex¹²,Sayan A. Emre¹^ORCID

Affiliation:

1. Cancer Sciences Division University of Southampton UK

2. College of Applied Medical Sciences University of Hafr Al‐Batin Saudi Arabia

3. Department of Molecular Biology and Genetics Gebze Technical University Turkey

4. Department of Surgery Southampton University Hospital NHS Trust UK

5. Department of Radiation Oncology Dana‐Farber Cancer Institute Harvard Medical School Boston MA USA

6. Molecular Cellular Oncology Lab Department for Biomedical Molecular Biology Ghent University Belgium

7. Cancer Research Institute Ghent (CRIG) Belgium

8. Department of Biomedical Sciences Nazarbayev University School of Medicine Astana Kazakhstan

Funder

Wessex Medical Research

Cancer Research UK